In a significant move for the healthcare sector, Dr. Agarwal’s Eye Hospital Limited (AEHL) is set to merge with Dr. Agarwal’s Health Care Limited (AHCL). This amalgamation represents a strategic consolidation of two major players in the Indian eye care industry, aiming to create a single, more efficient entity.
The Core of the Merger
The proposed scheme involves the amalgamation of AEHL (the Transferor Company) into AHCL (the Transferee Company). Following the completion of this process, AEHL will stand dissolved without being wound up, and its entire undertaking will be transferred to and vested in AHCL as a going concern.
This is not a sudden development; in its 2025 IPO prospectus, AHCL had already disclosed its intention to explore this merger to capitalize on business synergies.
Why This Merger Matters: Key Benefits
The companies believe this consolidation will unlock several strategic advantages:
- Operational and Financial Efficiencies: By pooling resources and standardizing protocols, the merged entity expects to achieve significant economies of scale and more economical management.
- Unified Capital Allocation: A single capital structure will allow for more agile and strategic allocation of resources toward future growth and strategic investments.
- Simplified Governance: The merger will eliminate multiple record-keeping requirements and streamline the legal and regulatory framework, allowing management to focus on a single, unified entity.
- Value for Shareholders: The transaction is expected to be EPS (Earnings Per Share) accretive from the very first year of implementation, maximizing returns for stakeholders.
Understanding the Share Exchange Ratio
For investors and shareholders, the “Share Exchange Ratio” is a critical detail. As recommended by independent valuers and merchant bankers, the ratio is set as follows: For every 2 equity shares held in AEHL (INR 10 face value), shareholders will receive 23 equity shares in AHCL (INR 1 face value).
A Powerhouse in Eye Care
The combined strength of these entities is formidable:
- AHCL was recognized as India’s largest eye care service chain by revenue for FY2024, boasting a network of 288 facilities across India and 19 across Africa as of March 2026.
- AEHL brings a predominant presence in Tamil Nadu with over 63 facilities and a team of more than 250 doctors.
What’s Next?
The merger has already received “No Objection” letters from major stock exchanges (NSE and BSE) and is proceeding under the directions of the National Company Law Tribunal (NCLT), Chennai Bench.
A pivotal meeting for Unsecured Creditors is scheduled for July 2, 2026, at 04:00 P.M. IST at The Music Academy in Chennai to consider and approve the scheme. Creditors should note that the scheme does not involve any compromise or reduction of their dues; all liabilities will be paid in full in the normal course of business.
This merger signals a new era for Dr. Agarwal’s, promising a more robust balance sheet and a streamlined path toward becoming a global leader in ophthalmic care.
source:corporate announcement